The variant the researchers found may increase the amount of the receptor protein on the cell surface, giving the drug more targets, Auton says
Circulation (2012) 126(15):183851.10.1161/CIRCULATIONAHA.112.096479 175 EltzschigHKFaigleMKnappSKarhausenJIblaJRosenbergerPet alEndothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26
doi:10.3109/10408444.2013.861798.[Taylor & Francis Online], [Web of Science ] , [Google Scholar] for reviews)
Semaglutide's structural improvements over liraglutide translate directly into superior clinical outcomes: approximately 2.5 times greater weight loss, lower treatment discontinuation, more convenient dosing, and broader cardiovascular evidence
GLP-1 receptor agonists are medicines
Once phase 3 completes and positive results are confirmed, Eli Lilly (or its partners) may file for FDA approval